JACQUELINE FRIEDE: Open Payments
NPI 1336858836 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,521 in 59 payments from 11 companies in 2025. Trend: 2023 $401 · 2024 $264 · 2025 $1,521
Food & beverage: $1,521
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $276 |
| Corcept Therapeutics | 14 | $243 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $218 |
| AstraZeneca Pharmaceuticals LP | 2 | $198 |
| Janssen Pharmaceuticals, Inc | 4 | $160 |
| Novo Nordisk Inc | 6 | $152 |
| Organogenesis Inc. | 1 | $130 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $48 |
| Amgen Inc. | 2 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $30 |
Products named: Korlym, CAPLYTA, INVEGA, UBRELVY, PURAPLY WOUND MATRIX, Ozempic, FARXIGA, VRAYLAR.
Industry payments across MT — which companies pay providers there.
